REMEDIUMREMEDIUM1561-59362658-3534Joint-Stock Company Chicot114410.21518/1561-5936-2019-10-52-57Original ArticleAnalysis of the Russian paediatric antibacterials marketNarkevichI. A.noemail@neicon.ruNemyatykhO. D.noemail@neicon.ruMedvedevaD. M.noemail@neicon.ruLadut'koYu. M.noemail@neicon.ruTerninkoT. M.noemail@neicon.ruZagalovD. E.noemail@neicon.ruMikhaylovaYu. V.noemail@neicon.ruSaint Petersburg State Chemical Pharmaceutical Academy1012201910525718032022Copyright © 2019,2019Improving the drug supply for children is one of the priority areas of the development of the Russian healthcare service. The article presents a multi-vector marketing analysis of the national paediatric antibacterials market. The objects of the research included the state register of medicinal products and data from DSM Group marketing agency. It was found that a significant (45%) share of medicinal products (MP) of J01 Group Antibacterials for systemic use, which is formed mainly by beta-lactam products and fluoroquinolones, is provided by the foreign manufacturers. At the same time, the medicinal products in the form of tablets (33%) and powders for preparation of solution for injection (26%) account for the maximum share in the assortment profile. Analysis of the proposal with a breakdown into age restrictions showed that only 24% of the assortment of authorized medicinal products are allowed to use for children aged less than 3 years old. It has been shown that the reproduced MPs currently cover 76.3 and 90.9% of the antibacterials sales pattern in value and physical terms, respectively. At the same time, the renewal index of J01 Antibacterials for systemic use was 2% over the past 5 years. Assessment of the assortment using the multidimensional method of Boston Consulting Group showed that 70% of items within the studied category of drugs are characterized by insignificant investment attractiveness, which is largely determined by the risks of product life cycle reduction in the settings of the development of bacterial resistance. The main parameters and characteristics of the assortment of J01 Antibacterials for systemic use market demonstrate the prospects for expanding the assortment portfolio of the Russian manufacturers due to drugs in the form of children's dosage forms that meet modern pharmacotherapy concepts in paediatrics.antibacterial drugsthe Russian marketpaediatricschildren's dosage formsassortmentантибактериальные препаратыроссийский рынокпедиатриядетские лекарственные формыассортимент1.Официальный сайт Всемирной Организации Здравоохранения. Режим доступа: https://www.who.int/ maternal_child_adolescent/topics /child /mortality/ru/. World Health Organization Official Website. (In Russ.) Available at: https://www.who.int/maternal_child_adolescent/topics/ child/mortality/ru/2.Сиукаева Д.Д. Оптимизация лекарственного обеспечения пациентов с внебольничной пневмонией в педиатрии: на примере стационаров Санкт-Петербурга: автореф. дис.. канд. фарм. наук: 14.04.03. СПб., 2019. 24 с. Siukaeva D.D. Optimization of drug support for patients with community-acquired pneumonia in pediatrics: as exemplified by hospitals in St. Petersburg: extended abstract of Cand. Sci. (Pharm.) Dissertation: 14.04.03. SPb., 2019. 24 p. (In Russ.)3.Сиукаева Д.Д., Наркевич И.А., Немятых О.Д., Басакина И.И. Анализ госпитальных закупок противомикробных препаратов системного действия на фармацевтическом рынке Северо-Западного федерального округа. Научные ведомости Белгородского государственного университета Медицина. Фармация. 2018;41(4):672-686. Режим доступа: https://elibrary.ru/item.asp?id=36742569@@Siukaeva D.D., Narkevich I.A., Nemyatych O.D., Basakina I.I. Analysis of hospital purchases of antimicrobialdrugs in the framework of the pharmaceutical market the NorthWestern Federal District. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta Meditsina. Farmatsiya. = Belgorod State University Scientific bulletin. Medicine. Pharmacy. 2018;41(4):672-686. (In Russ.) Available at: https://elibrary.ru/ item.asp?id=36742569.4.Сиукаева Д.Д., Немятых О.Д., Наркевич И.А., Павленко Н.И. Комплексная маркетинговая оценка рынка лекарственных средств для лечения пневмонии у детей. Разработка и регистрация лекарственных средств. 2017;(4):292-296. Режим доступа: https://www.pharmjournal.ru/jour/article/ view/531@@Siukaeva D.D., Nemyatyh O.D., Narkevich I.A., Pavlenko N.I. Comprehensive assessment of the market drugs for treatment of pneumonia in pediatrics. Drug development & registration. 2017;(4):292-296. (In Russ.) Available at: https:/www. pharmjournal.ru/jour/article/view/531.5.Государственный реестр лекарственных средств. Режим доступа:: http://grls.rosminzdrav.ru/Default.aspx@@State register of medicinal products. (In Russ.) Available at: http://grls.rosminzdrav.ru/Default.aspx.6.База данных аналитического агентства DSM Group Режим доступа: https://dsmviewer.ru/LoginForm. aspx?ReturnUrl=%2fReportManager.aspx@@DSM Group analytical agency database. (In Russ.) Available at: https://dsmviewer.ru/LoginForm. aspx?ReturnUrl=%2fReportManager.aspx7.Наркевич И.А., Немятых О.Д., Басакина И.И., Сиукаева Д.Д. Фармацевтическая разработка лекарственных препаратов для педиатрической практики: фундаментальные основы и специфические особенности. Разработка и регистрация лекарственных средств. 2016;(3):194-201. Режим доступа: https://www.pharmjournal.ru/jour/article/view/310@@Narkevich I.A., Nemyatykh O.D., Basakina I.I., Siukaeva D.D. Pharmaceutical development of drugs for pediatric practice: fundamental bases and specific features. Drug development & registration. 2016;(3):194-201. (In Russ.) Available at: https:// www.pharmjournal.ru/jour/article/view/310.8.Morel C.M., Mossialos Stoking the antibiotic pipeline. BMJ. 2010;340:c2115. doi: 10.1136/bmj.c2115.